tradingkey.logo

Microbot Medical Inc

MBOT
2.255USD
+0.175+8.41%
交易中 美東報價延遲15分鐘
148.45M總市值
虧損本益比TTM

Microbot Medical Inc

2.255
+0.175+8.41%

關於 Microbot Medical Inc 公司

Microbot Medical Inc. is a pre-commercial stage medical technology company. It has developed the single-use, fully disposable endovascular robotic system, which aims to eliminate traditional barriers to accessing advanced robotic systems. It specializes in the research, design and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. Using its LIBERTY technological platform, it is developing a fully disposable robot for various endovascular interventional procedures. The LIBERTY Endovascular Robotic Surgical System is designed to maneuver guidewires and over-the-wire devices (such as microcatheters) within the body’s vasculature. It eliminates the need for extensive capital equipment requiring dedicated Cath-lab rooms as well as dedicated staff. Its addressable markets for the LIBERTY Endovascular Robotic Surgical System include the peripheral interventional radiology, interventional cardiology and interventional neuroradiology markets.

Microbot Medical Inc簡介

公司代碼MBOT
公司名稱Microbot Medical Inc
上市日期Mar 25, 1992
CEOGadot (Harel)
員工數量21
證券類型Ordinary Share
年結日Mar 25
公司地址175 Derby St Bld 27
城市HINGHAM
上市交易所NASDAQ OMX - NASDAQ BASIC
國家United States of America
郵編02043
電話17818753605
網址http://www.microbotmedical.com/
公司代碼MBOT
上市日期Mar 25, 1992
CEOGadot (Harel)

Microbot Medical Inc公司高管

名稱
名稱/職務
職務
持股
持股變動
Mr. Tal Wenderow
Mr. Tal Wenderow
Independent Director
Independent Director
--
--
Mr. David J. Wilson
Mr. David J. Wilson
Independent Director
Independent Director
--
--
Mr. Prattipati Laxminarain
Mr. Prattipati Laxminarain
Independent Director
Independent Director
--
--
Dr. Juan Diaz-Cartelle
Dr. Juan Diaz-Cartelle
Chief Medical Officer
Chief Medical Officer
--
--
Ms. Rachel Vaknin
Ms. Rachel Vaknin
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Harel Gadot
Mr. Harel Gadot
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
--
--
Mr. Scott R. Burell
Mr. Scott R. Burell
Independent Director
Independent Director
--
--
Ms. Aileen Ptucha Stockburger, CPA
Ms. Aileen Ptucha Stockburger, CPA
Independent Director
Independent Director
--
--
Mr. Simon Sharon
Mr. Simon Sharon
Chief Technology Officer, General Manager of Microbot Israel
Chief Technology Officer, General Manager of Microbot Israel
--
--
Mr. Martin J. Madden
Mr. Martin J. Madden
Independent Director
Independent Director
--
--
名稱
名稱/職務
職務
持股
持股變動
Mr. Tal Wenderow
Mr. Tal Wenderow
Independent Director
Independent Director
--
--
Mr. David J. Wilson
Mr. David J. Wilson
Independent Director
Independent Director
--
--
Mr. Prattipati Laxminarain
Mr. Prattipati Laxminarain
Independent Director
Independent Director
--
--
Dr. Juan Diaz-Cartelle
Dr. Juan Diaz-Cartelle
Chief Medical Officer
Chief Medical Officer
--
--
Ms. Rachel Vaknin
Ms. Rachel Vaknin
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Harel Gadot
Mr. Harel Gadot
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
--
--

收入明細

由於公司未披露,未能獲取相關數據
由於公司未披露,未能獲取相關數據
業務
地區
由於公司未披露,未能獲取相關數據

股東統計

更新時間: 11月25日 週二
更新時間: 11月25日 週二
持股股東
股東類型
持股股東
持股股東
佔比
The Vanguard Group, Inc.
3.49%
CIBC Private Wealth Management
2.17%
Susquehanna International Group, LLP
1.86%
Heights Capital Management, Inc.
1.31%
Geode Capital Management, L.L.C.
0.73%
其他
90.43%
持股股東
持股股東
佔比
The Vanguard Group, Inc.
3.49%
CIBC Private Wealth Management
2.17%
Susquehanna International Group, LLP
1.86%
Heights Capital Management, Inc.
1.31%
Geode Capital Management, L.L.C.
0.73%
其他
90.43%
股東類型
持股股東
佔比
Investment Advisor
8.12%
Investment Advisor/Hedge Fund
4.56%
Research Firm
0.49%
Hedge Fund
0.43%
Venture Capital
0.20%
Bank and Trust
0.04%
其他
86.16%

機構持股

更新時間: 10月1日 週三
更新時間: 10月1日 週三
報告期間
機構數
持股數
持股佔比
持股變動
2025Q3
108
5.08M
9.55%
-906.12K
2025Q2
93
3.71M
8.26%
-749.31K
2025Q1
89
2.58M
7.86%
-1.62M
2024Q4
78
1.58M
4.97%
-880.54K
2024Q3
70
1.52M
8.93%
-946.72K
2024Q2
71
1.56M
9.80%
-833.62K
2024Q1
69
2.54M
18.61%
-153.32K
2023Q4
67
2.61M
22.30%
+489.30K
2023Q3
65
2.09M
17.88%
-264.50K
2023Q2
64
2.33M
23.62%
-218.94K
查看更多

股東持股明細

名稱
持股數
佔比
持股變動
變動比例
公告日期
The Vanguard Group, Inc.
2.05M
3.86%
+1.31M
+176.68%
Jun 30, 2025
CIBC Private Wealth Management
612.00K
1.15%
+612.00K
--
Jun 30, 2025
Susquehanna International Group, LLP
31.84K
0.06%
-72.34K
-69.44%
Jun 30, 2025
Geode Capital Management, L.L.C.
395.04K
0.74%
+78.12K
+24.65%
Jun 30, 2025
BlackRock Institutional Trust Company, N.A.
313.96K
0.59%
+77.85K
+32.97%
Jun 30, 2025
DNB Asset Management AS
192.79K
0.36%
+77.97K
+67.90%
Jun 30, 2025
State Street Investment Management (US)
138.52K
0.26%
+1.85K
+1.35%
Jun 30, 2025
查看更多

持股ETF

更新時間: 12月6日 週六
更新時間: 12月6日 週六
機構名稱
佔比
iShares Micro-Cap ETF
0.01%
Avantis US Small Cap Equity ETF
0%
iShares Core S&P Total U.S. Stock Market ETF
0%
iShares Micro-Cap ETF
佔比0.01%
Avantis US Small Cap Equity ETF
佔比0%
iShares Core S&P Total U.S. Stock Market ETF
佔比0%

分紅派息

近5年累計派現 0.00 美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
暫無數據

拆合股

公告日期
類型
比率
暫無數據
公告日期
類型
比率
暫無數據

常見問題

Microbot Medical Inc的前五大股東是誰?

Microbot Medical Inc的前五大股東如下:
The Vanguard Group, Inc.
持有股份:2.05M
佔總股份比例:3.86%。
CIBC Private Wealth Management
持有股份:612.00K
佔總股份比例:1.15%。
Susquehanna International Group, LLP
持有股份:31.84K
佔總股份比例:0.06%。
Geode Capital Management, L.L.C.
持有股份:395.04K
佔總股份比例:0.74%。
BlackRock Institutional Trust Company, N.A.
持有股份:313.96K
佔總股份比例:0.59%。

Microbot Medical Inc的前三大股東類型是什麼?

Microbot Medical Inc 的前三大股東類型分別是:
The Vanguard Group, Inc.
CIBC Private Wealth Management
Susquehanna International Group, LLP

有多少機構持有Microbot Medical Inc(MBOT)的股份?

截至2025Q3,共有108家機構持有Microbot Medical Inc的股份,合計持有的股份價值約為5.08M,占公司總股份的9.55% 。與2025Q2相比,機構持股有所增加,增幅為1.29%。

哪個業務部門對Microbot Medical Inc的收入貢獻最大?

在--,--業務部門對Microbot Medical Inc的收入貢獻最大,創收--,占總收入的--% 。
KeyAI